Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04107181 · ClinicalTrials.gov registry record · NA

Pilot Study for Speculum Free Cervical Cancer Screening

A NA study of Cervical Cancer, sponsored by Duke University.

Recruiting
Registry status
NA
Development phase
305
Enrollment target
1
Study location

NCT04107181: Recruiting NA study of Cervical Cancer, sponsored by Duke University.

NCT04107181 is a NA study of Cervical Cancer that is actively recruiting participants, run by Duke University. The registered enrollment target is 305 participants, below the 568-participant average among 144 other Cervical Cancer trials with a reported enrollment target (46% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04107181, a NA study of Cervical Cancer, is actively recruiting participants, sponsored by Duke University.

RECRUITING
Registry status
NA
Development phase
305 participants
Enrollment target
1
Study location

Study Summary

The objective of the work described in this protocol is to determine the optical signatures of cervical dysplasia using optical technologies.

Primary Outcome

We will conduct interviews/surveys to determine if subjects enrolled prefer introducer over SOC speculum

Conditions Studied

Interventions

  • DEVICE Introducer "calla" device
  • BEHAVIORAL Interviews only

Study Locations (1)

North Carolina

  • Duke University - Durham

Trial Details

FieldValue
Enrollment Target 305 participants
Start Date 2016-04-14
Est. Completion 2028-02-01
Phase NA
Duke University

1,725 total trials

What NCT04107181 shows while recruiting

NCT04107181 is an interventional study that assigns participants to a tested intervention. The registered 305 participants enrollment target is mid-sized for trials with a published cap, below the 568-participant average among 144 other Cervical Cancer trials with a reported enrollment target (46% lower).

The record links to 1 condition, with Cervical Cancer appearing as the primary indexed condition, and to 2 interventions - of which Introducer "calla" device is the first listed.

NCT04107181 reports a single indexed study location in North Carolina.

Frequently Asked Questions

What is clinical trial NCT04107181 about?

NCT04107181 is a clinical study titled "Pilot Study for Speculum Free Cervical Cancer Screening". The objective of the work described in this protocol is to determine the optical signatures of cervical dysplasia using optical technologies.

What is the current status of trial NCT04107181?

This trial is currently recruiting. It is a NA study. The enrollment target is 305 participants. The study started on 2016-04-14. Estimated completion is 2028-02-01.

What conditions does trial NCT04107181 study?

This clinical trial studies the following conditions: Cervical Cancer.

What interventions are being tested in trial NCT04107181?

The interventions under investigation include: Introducer "calla" device (DEVICE), Interviews only (BEHAVIORAL).

Who is sponsoring clinical trial NCT04107181?

This trial is sponsored by Duke University, which has 1,725 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04107181 being conducted?

This trial has 1 study location across North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Cervical Cancer

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT04107181's enrollment target sits among peer trials

305 38th of 144 higher than 107 of 144 other Cervical Cancer trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Cervical Cancer trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT05399056 · 305 participants · NA

    Improving Participation in Pulmonary Rehabilitation Through Peer Support and Storytelling

  • NCT05078970 · 306 participants · NA

    Advancing Suicide Intervention Strategies for Teens During High Risk Periods

  • NCT05843695 · 306 participants · NA

    Enhancing Psychotherapy for Veterans and Service Members With PTSD and Anxiety

  • NCT06057337 · 306 participants · NA

    Families With Pride ("Familias Con Orgullo").

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT04107181, the US trial registry maintained by the National Library of Medicine. NCT04107181 (mid enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.